Literature DB >> 7586333

Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.

B S Coller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586333     DOI: 10.1161/01.cir.92.9.2373

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  35 in total

Review 1.  Small-molecule glycoprotein IIb/IIIa inhibitors as adjunctive therapy in percutaneous coronary interventions.

Authors:  J C O'Shea; J E Tcheng
Journal:  J Thromb Thrombolysis       Date:  2000-12       Impact factor: 2.300

Review 2.  Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.

Authors:  M T Roe; D J Moliterno
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

Review 3.  Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions.

Authors:  J J Ferguson; M Zaqqa
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

4.  Old concepts and new developments in the study of platelet aggregation.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade.

Authors:  P W Armstrong
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 6.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

7.  Nanoparticle-induced platelet aggregation and vascular thrombosis.

Authors:  Anna Radomski; Paul Jurasz; David Alonso-Escolano; Magdalena Drews; Maria Morandi; Tadeusz Malinski; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 8.  Antiplatelet drugs.

Authors:  Gustav Born; Carlo Patrono
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

9.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

10.  Acute Profound Thrombocytopenia after Using Abciximab for No-Reflow during Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.

Authors:  Soonyoung Park; Jooyoung Lee; Sang Yeub Lee; Jang-Whan Bae; Kyung-Kuk Hwang; Dong-Woon Kim; Myeong-Chan Cho; Sang Min Kim
Journal:  Korean Circ J       Date:  2013-08-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.